Physician profile

Christine S Haddad

Pain Medicine · Phoenix, AZ

NPI 1972965168

$97,739.43

in general payments reported to CMS, 2019-2025

37 companies · $43K in 2025

The $43K reported for 2025 was more than what 98% of Pain Medicine providers received nationally (typical 2025 total: $515).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$55,072.50
Food and Beverage$14,706.69
Travel and Lodging$13,218.07
Consulting Fee$495.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $43,914.79 2021-2025 Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray
Boston Scientific Corporation $31,935.80 2020-2025 Intracept, Wavewriter Alpha Prime 16, Na
Abbott Laboratories $10,016.57 2021-2025 Proclaim, Eterna, Octrode
Relievant Medsystems, INC. $4,335.49 2023 Intracept
Nevro Corp. $1,948.30 2020-2024 Senza
Spinal Simplicity, LLC $1,380.21 2022-2025 Ha Minuteman G3-R
Nalu Medical, INC. $1,271.12 2023-2025 Nalu Neurostimulation System
Painteq LLC $459.67 2023-2024 Painteq
Saluda Medical Americas, INC. $394.36 2023-2025 Evoke, Evoke Scs
Spr Therapeutics, INC $232.76 2020-2025 Sprint Pns System
Vertos Medical, INC. $192.77 2022-2024 Mild Device Kit
Avanos Medical $175.96 2021-2023 Generator
Protega Pharmaceutials INC $175.13 2024-2025 Roxybond
Biotronik Nro, INC. $156.60 2024-2025 Prospera
Nuvasive, INC. $123.19 2021-2023 Alif
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Abbvie INC. $113.44 2022-2025
Averitas Pharma INC. $107.30 2023-2025 Qutenza
Arbor Pharmaceuticals, INC. $104.95 2021-2022
Grt US Holding, INC. $92.98 2021-2022
Collegium Pharmaceutical, INC. $78.29 2023-2024 Xtampza, Belbuca
Globus Medical, INC. $65.31 2025 Senza
Vertex Pharmaceuticals Incorporated $55.48 2024
Electronic Waveform Lab, INC. $53.63 2024
Foundation Fusion Solutions, LLC $37.79 2024
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $37.52 2025 Relistor
Ferring Pharmaceuticals INC. $35.42 2022
Medtronic USA, INC. $35.00 2020
Bioventus LLC $34.96 2025 Supartz Fx Sodium Hyaluronate
Biodelivery Sciences International, INC. $29.57 2021
Stryker Corporation $20.71 2021
Otto Bock Healthcare Lp $19.99 2022
Valinor Pharma, LLC $19.63 2023 Movantik
Depuy Synthes Sales INC. $19.60 2023 Monovisc, Orthovisc
Scilex Pharmaceuticals INC. $18.70 2023 Ztlido
Allergan, INC. $16.77 2021
Arteriocyte Medical Systems, INC. $15.59 2025 Magellan
Tonix Medicines, INC. $14.08 2025 Tonmya

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christine S Haddad

$97,739.43

in general payments reported 2019-2025

Years
2020-2025
Top company
Medtronic, INC.
Context
The $43K reported for 2025 was more than what 98% of Pain Medicine providers received nationally (typical 2025 total: $515).

https://glasscript.com/doctor/8691905/christine-s-haddad

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.